These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 35285607)

  • 1. Infectious disease in respiratory medicine.
    Kent BD
    Breathe (Sheff); 2022 Mar; 18(1):220022. PubMed ID: 35285607
    [No Abstract]   [Full Text] [Related]  

  • 2. Coronavirus Disease 2019: Quick Diet and Nutrition Guide for Patients With Chronic Kidney Disease.
    Mafra D; Cardozo LFMF; Moraes C; Moreira LSG; Teixeira KTR; Reis DCMV; Fanton S; Salarolli R; Kalantar-Zadeh K; Burrowe JD
    J Ren Nutr; 2021 Jan; 31(1):39-42. PubMed ID: 32952005
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optimal treatment of the underlying aetiology is the most effective antimicrobial stewardship for chronic respiratory disease: a lesson learned from cystic fibrosis.
    Rademacher J; Martin L; Theloe A; Stahl M; Mall MA; Joean O; Fuge J; Hansen G; Welte T; Schütz K; Ringshausen FC; Dittrich AM
    ERJ Open Res; 2023 Jul; 9(4):. PubMed ID: 37650087
    [No Abstract]   [Full Text] [Related]  

  • 4. Disease definitions in respiratory and sleep medicine: changes in diagnostic criteria and categories over time and clinical implications.
    Dobler CC
    Breathe (Sheff); 2021 Sep; 17(3):210117. PubMed ID: 35035561
    [No Abstract]   [Full Text] [Related]  

  • 5. Celebrating 10 years of ERS HERMES examination in paediatric respiratory medicine.
    Cawley SJ
    Breathe (Sheff); 2020 Jun; 16(2):200048. PubMed ID: 33304405
    [No Abstract]   [Full Text] [Related]  

  • 6. Pulmonary vascular disease for the general respiratory clinician.
    Kent BD
    Breathe (Sheff); 2022 Dec; 18(4):220261. PubMed ID: 36867114
    [No Abstract]   [Full Text] [Related]  

  • 7. The exposome concept: how has it changed our understanding of environmental causes of chronic respiratory diseases?
    Guillien A; Ghosh M; Gille T; Dumas O
    Breathe (Sheff); 2023 Jun; 19(2):230044. PubMed ID: 37492345
    [No Abstract]   [Full Text] [Related]  

  • 8. Respiratory healthcare professionals' views on long-term recommendations of interventions to prevent acute respiratory illnesses after the COVID-19 pandemic.
    Yaacoby-Bianu K; Livnat G; Chalmers JD; Shteinberg M
    ERJ Open Res; 2022 Oct; 8(4):. PubMed ID: 36199591
    [No Abstract]   [Full Text] [Related]  

  • 9. Comparing traditional bibliometrics and Altmetric assessments of research impact in respiratory disease.
    Dutt E; Hurst JR
    ERJ Open Res; 2023 Nov; 9(6):. PubMed ID: 38020558
    [No Abstract]   [Full Text] [Related]  

  • 10. In the spotlight: Early Career Member Awardee 2020, ERS Lung Science Conference 2021, and Sleep and Breathing 2021.
    Martinez Alejos R; Harrison SL; Crespo A; Ubags ND; De Brandt J
    Breathe (Sheff); 2020 Dec; 16(4):200199. PubMed ID: 33447288
    [No Abstract]   [Full Text] [Related]  

  • 11. Targeted therapy in respiratory disease.
    Kent BD
    Breathe (Sheff); 2021 Dec; 17(4):210170. PubMed ID: 35035575
    [No Abstract]   [Full Text] [Related]  

  • 12. Pulmonary embolism: yet another cause of hypoxaemic respiratory failure in COVID-19.
    Nieri D; Lenzini G; Canari Venturi B; Celi A
    ERJ Open Res; 2020 Apr; 6(2):. PubMed ID: 32523963
    [No Abstract]   [Full Text] [Related]  

  • 13. Impact of the COVID-19 Pandemic on Antibiotic Prescribing for Common Infections in The Netherlands: A Primary Care-Based Observational Cohort Study.
    van de Pol AC; Boeijen JA; Venekamp RP; Platteel T; Damoiseaux RAMJ; Kortekaas MF; van der Velden AW
    Antibiotics (Basel); 2021 Feb; 10(2):. PubMed ID: 33670657
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dyspnoea and clinical outcome in critically ill patients receiving noninvasive support for COVID-19 respiratory failure:
    Menga LS; Grieco DL; Rosà T; Cesarano M; Delle Cese L; Berardi C; Pintaudi G; Tanzarella ES; Cutuli SL; De Pascale G; Maggiore SM; Antonelli M
    ERJ Open Res; 2021 Oct; 7(4):. PubMed ID: 34611526
    [No Abstract]   [Full Text] [Related]  

  • 15. A double-edged sword.
    Vandebotermet M; Staels F; Giovannozzi S; Delforge M; Tousseyn T; Steelandt T; Corveleyn A; Meyts I; Maertens J; Yserbyt J; Schrijvers R
    Breathe (Sheff); 2020 Sep; 16(3):200017. PubMed ID: 33447267
    [No Abstract]   [Full Text] [Related]  

  • 16. COVID-19 associated pulmonary aspergillosis: a nationwide survey by the Japanese Respiratory Society.
    Takazono T; Mukae H; Izumikawa K; Hasegawa N; Yokoyama A
    ERJ Open Res; 2021 Oct; 7(4):. PubMed ID: 34703830
    [No Abstract]   [Full Text] [Related]  

  • 17. Time to negative conversion and cardiopulmonary performance in athletes with COVID-19.
    Mone P; Bencivenga L; Santulli G; Rengo G; Guerra G; Komici K
    ERJ Open Res; 2024 Jul; 10(4):. PubMed ID: 39040592
    [No Abstract]   [Full Text] [Related]  

  • 18. Key role of dysregulated airway epithelium in response to respiratory viral infections in asthma.
    Moheimani F; Shahdab N; Cummings S; Hansbro PM; Ward C
    ERJ Open Res; 2022 Jul; 8(3):. PubMed ID: 36171982
    [No Abstract]   [Full Text] [Related]  

  • 19. Rapid decline of seasonal influenza during the outbreak of COVID-19.
    Young G; Peng X; Rebeza A; Bermejo S; De C; Sharma L; Dela Cruz CS
    ERJ Open Res; 2020 Jul; 6(3):. PubMed ID: 32832527
    [No Abstract]   [Full Text] [Related]  

  • 20. Type 2 respiratory failure secondary to left hemidiaphragmatic paralysis.
    Fiott DL; Gauci J; Pace Bardon M; Balzan M
    Breathe (Sheff); 2022 Mar; 18(1):210165. PubMed ID: 36338253
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.